Similar articles for PMID: 21457426

Year	Number of Results
2000	2
2001	3
2002	7
2003	3
2004	9
2005	6
2006	6
2007	12
2008	7
2009	10
2010	4
2011	12
2012	5
2013	6
2014	5
2015	2
2016	6
2017	1
2018	1
2019	2
2020	1
2021	1
2024	0

1

High-density lipoprotein-cholesterol and not HbA1c was directly related to cardiovascular outcome in PROactive.

Ferrannini E, Betteridge DJ, Dormandy JA, Charbonnel B, Wilcox RG, Spanheimer R, Erdmann E, Defronzo RA, Laakso M. Ferrannini E, et al. Diabetes Obes Metab. 2011 Aug;13(8):759-64. doi: 10.1111/j.1463-1326.2011.01404.x. Diabetes Obes Metab. 2011. PMID: 21457426 Clinical Trial.

2

Long-term lipid effects of pioglitazone by baseline anti-hyperglycemia medication therapy and statin use from the PROactive experience (PROactive 14).

Spanheimer R, Betteridge DJ, Tan MH, Ferrannini E, Charbonnel B; PROactive Investigators. Spanheimer R, et al. Am J Cardiol. 2009 Jul 15;104(2):234-9. doi: 10.1016/j.amjcard.2009.03.023. Epub 2009 Jun 3. Am J Cardiol. 2009. PMID: 19576353 Clinical Trial.

3

Pioglitazone Randomised Italian Study on Metabolic Syndrome (PRISMA): effect of pioglitazone with metformin on HDL-C levels in Type 2 diabetic patients.

Genovese S, Passaro A, Brunetti P, Comaschi M, Cucinotta D; PRISMA study group; Egan CG, Chinea B, Bravi F, Di Pietro C. Genovese S, et al. J Endocrinol Invest. 2013 Sep;36(8):606-16. doi: 10.3275/8895. Epub 2013 Mar 19. J Endocrinol Invest. 2013. PMID: 23511244 Clinical Trial.

4

The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus.

Rosenblatt S, Miskin B, Glazer NB, Prince MJ, Robertson KE; Pioglitazone 026 Study Group. Rosenblatt S, et al. Coron Artery Dis. 2001 Aug;12(5):413-23. doi: 10.1097/00019501-200108000-00011. Coron Artery Dis. 2001. PMID: 11491207 Clinical Trial.

5

Lowering the triglyceride/high-density lipoprotein cholesterol ratio is associated with the beneficial impact of pioglitazone on progression of coronary atherosclerosis in diabetic patients: insights from the PERISCOPE (Pioglitazone Effect on Regression of Intravascular Sonographic Coronary Obstruction Prospective Evaluation) study.

Nicholls SJ, Tuzcu EM, Wolski K, Bayturan O, Lavoie A, Uno K, Kupfer S, Perez A, Nesto R, Nissen SE. Nicholls SJ, et al. J Am Coll Cardiol. 2011 Jan 11;57(2):153-9. doi: 10.1016/j.jacc.2010.06.055. J Am Coll Cardiol. 2011. PMID: 21211686 Free article. Clinical Trial.

6

A meta-analysis comparing the effect of thiazolidinediones on cardiovascular risk factors.

Chiquette E, Ramirez G, Defronzo R. Chiquette E, et al. Arch Intern Med. 2004 Oct 25;164(19):2097-104. doi: 10.1001/archinte.164.19.2097. Arch Intern Med. 2004. PMID: 15505122

7

Pioglitazone hydrochloride in combination with sulfonylurea therapy improves glycemic control in patients with type 2 diabetes mellitus: a randomized, placebo-controlled study.

Kipnes MS, Krosnick A, Rendell MS, Egan JW, Mathisen AL, Schneider RL. Kipnes MS, et al. Am J Med. 2001 Jul;111(1):10-7. doi: 10.1016/s0002-9343(01)00713-6. Am J Med. 2001. PMID: 11448655 Clinical Trial.

8

Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial.

Derosa G, Cicero AF, D'Angelo A, Gaddi A, Ciccarelli L, Piccinni MN, Salvadeo SA, Pricolo F, Ferrari I, Gravina A, Ragonesi PD. Derosa G, et al. Clin Ther. 2006 May;28(5):679-88. doi: 10.1016/j.clinthera.2006.05.012. Clin Ther. 2006. PMID: 16861090 Clinical Trial.

9

Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: a randomized, placebo-controlled study. The Pioglitazone 027 Study Group.

Einhorn D, Rendell M, Rosenzweig J, Egan JW, Mathisen AL, Schneider RL. Einhorn D, et al. Clin Ther. 2000 Dec;22(12):1395-409. doi: 10.1016/s0149-2918(00)83039-8. Clin Ther. 2000. PMID: 11192132 Clinical Trial.

10

Determinants of an optimal response to pioglitazone in terms of HDL-cholesterol.

Kabeya Y, Tomita M, Asai Y, Katsuki T, Oikawa Y, Meguro S, Shimada A, Atsumi Y. Kabeya Y, et al. Intern Med. 2011;50(8):825-31. doi: 10.2169/internalmedicine.50.4853. Epub 2011 Apr 15. Intern Med. 2011. PMID: 21498929 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

105 results

Results by year